Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_assertion type Assertion NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_head.
- NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_assertion description "[Thus, attenuation of MCP-1 upregulation by inhibiting ERK phosphorylation might be a promising approach to treat CMT1X and other so far untreatable inherited peripheral neuropathies in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_provenance.
- NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_assertion evidence source_evidence_literature NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_provenance.
- NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_assertion SIO_000772 20591826 NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_provenance.
- NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_assertion wasDerivedFrom befree-2016 NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_provenance.
- NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_assertion wasGeneratedBy ECO_0000203 NP822619.RAafTXhly3zOxuwxPgOgO6utLbTCHYxgooRwBYVZW9gVA130_provenance.